Screener
Ardelyx ARDX North America — Total revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ardelyx in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Ardelyx’s 10-K, filed February 19, 2026.
- Filed
- Feb 19, 2026, 4:05 PM EST
- Fiscal year
- FY2025
- Accession
- 0001437402-26-000013
FAQ
- What is Ardelyx's north america — total revenues?
- Ardelyx (ARDX) reported north america — total revenues of $85.5K in Q4 2025.
- How has Ardelyx's north america — total revenues changed year-over-year?
- Ardelyx's north america — total revenues increased by 338.5% year-over-year, from $19.5K to $85.5K.
- What is the long-term trend for Ardelyx's north america — total revenues?
- Over 4 years (2021 to 2025), Ardelyx's north america — total revenues has grown at a 126.5% compound annual growth rate (CAGR), from $13K to $342K.
- What does north america — total revenues mean?
- This metric represents the total gross revenue generated from all commercial activities, product sales, and licensing agreements within the North American geographic market. It serves as a primary indicator of the company's commercial traction and market penetration for its therapeutic portfolio in this specific region. Tracking this figure allows investors to evaluate the success of regional go-to-market strategies and the adoption rate of the company's proprietary medicines.
Ask your AI about Ardelyx's north america — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude